Log in to save to my catalogue

Upregulation of fractalkine contributes to the proliferative response of prostate cancer cells to hy...

Upregulation of fractalkine contributes to the proliferative response of prostate cancer cells to hy...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A439109649

Upregulation of fractalkine contributes to the proliferative response of prostate cancer cells to hypoxia via promoting the [G.sub.1]/S phase transition

About this item

Full title

Upregulation of fractalkine contributes to the proliferative response of prostate cancer cells to hypoxia via promoting the [G.sub.1]/S phase transition

Publisher

Spandidos Publications

Journal title

Molecular Medicine Reports, 2015, p.7907

Language

English

Formats

Publication information

Publisher

Spandidos Publications

More information

Scope and Contents

Contents

Hypoxia is a common phenomenon in prostate cancer, which leads to cell proliferation and tumor growth. Fractalkine (FKN) is a membrane-bound chemokine, which is implicated in the progression of human prostate cancer and skeletal metastasis. However, the association between FKN and hypoxia-induced prostate cancer cell proliferation remains to be elu...

Alternative Titles

Full title

Upregulation of fractalkine contributes to the proliferative response of prostate cancer cells to hypoxia via promoting the [G.sub.1]/S phase transition

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A439109649

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A439109649

Other Identifiers

ISSN

1791-2997

DOI

10.3892/mmr.2015.4438

How to access this item